Patricia Mann is an associate in the firm’s Technology & Life Sciences group.

Ms. Mann represents biotechnology, pharmaceutical, diagnostic, medical and other life sciences industry clients with regard to intellectual property matters, including in connection with licensing and strategic alliances, M&A and commercial transactions.

Ms. Mann regularly counsels clients on structuring, negotiating and drafting various third-party agreements, including inbound and outbound licenses for patented and other technologies, development and commercialization collaborations, and manufacturing, supply, material transfer, sponsored research, clinical trial and services agreements.

Areas of Practice
Domaines D’Expertise





Ms. Mann’s representative experience includes the following:

Strategic Alliances and Collaborations:

  • Obsidian Therapeutics Inc. in its multiyear collaboration with Celgene Corporation to develop novel, regulated cell therapies for an upfront cash payment and an equity investment from Celgene for exclusive options to globally license the programs under the collaboration
  • Kyn Therapeutics Inc. in its strategic collaboration with Celgene Corporation to develop novel immuno-oncology therapies for an upfront cash payment of $80 million and an equity investment from Celgene for exclusive options to globally license the Kynase and AHR antagonist programs
  • Aegerion Pharmaceuticals, Inc. in its exclusive licensing agreement with Recordati Rare Diseases Inc. for the commercialization of JUXTAPID® (lomitapide) in Japan for a $25 million upfront payment, plus commercial milestones up to a total of $80 million and a royalty
Professional Experience

Prior to joining Goodwin in 2018, Ms. Mann worked for approximately three years as Senior Manager & Associate Corporate Counsel in the Corporate Legal group at Vertex Pharmaceuticals Incorporated, where she managed intellectual property licensing and drafted and negotiated contracts for Vertex’s pharmaceutical operations, research and development, quality assurance and preclinical development.  At Vertex, Ms. Mann led business development efforts with respect to a number of transactions, including the transaction described here: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines. Ms. Mann’s in-house background provides her with a unique perspective on her clients’ legal needs.

Prior to Ms. Mann’s time at Vertex, she clerked for the Honorable Gregory I. Massing at the Massachusetts Court of Appeals.


In 2019, Ms. Mann was chosen for membership into the National Black Lawyers – Top 40 Under 40 organization.

In The News









J.D., 2014
Suffolk University Law School
B.A., 2011
University of Delaware


Massachusetts Appeals Court, Honorable Gregory I. Massing



New York
District of Columbia
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique